Update of the pathophysiology of the restless-legs-syndrome

Movement Disorders

Volumn 22, Issue SUPPL. 18, 2007, Pages

  Paulus, Walter ^a   Dowling, Pascal ^a   Rijsman, Roselyne ^b   Stiasny Kolster, Karin ^c   Trenkwalder, Claudia ^d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Centre of Parkinsonism and Movement Disorders   (Germany)

Author keywords

Dopamine; Genetics; MEIS1; Pathophysiology; Restless legs

Indexed keywords

ANTICONVULSIVE AGENT; DIPRENORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; HOMEODOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE RECEPTOR; OXIDOPAMINE; PREGABALIN; PROTEIN BTBD9; PROTEIN MEIS1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LBXCOR1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

BASAL GANGLION; BRAIN CORTEX; BRAIN REGION; CONFERENCE PAPER; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FUNCTION; GENETIC RISK; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; THALAMUS;

HUMANS; NERVOUS SYSTEM; RESTLESS LEGS SYNDROME;

EID: 38049010506     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21824     Document Type: Conference Paper

References (80)

1. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000-1006.
2. Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C, de Weerd A. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007;22:1451-1456.
3. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:703-705.
4. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007;22 (Suppl. 18):S440-S448.
5. Cervenka S, Palhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006;129 (Part 8):2017-2028.
6. von Spiczak S, Whone AL, Hammers A, et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005;128 (Part 4):906-917.
7. Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 1997;41:639-645.
8. Tergau F, Wischer S, Paulus W. Motor system excitability in patients with restless legs syndrome. Neurology 1999;52:1060-1063.
9. Nardone R, Ausserer H, Bratti A, et al. Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurol Scand 2006;114:244-249.
10. Quatrale R, Manconi M, Gastaldo E, et al. Neurophysiological study of corticomotor pathways in restless legs syndrome. Clin Neurophysiol 2003;114:1638-1645.
11. Rau C, Hummel F, Gerloff C. Cortical involvement in the generation of "involuntary" movements in restless legs syndrome. Neurology 2004;62:998-1000.
12. Trenkwalder C, Bucher SF, Oertel WH, Proeckl D, Plendl H, Paulus W. Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroencephalogr Clin Neurophysiol 1993;89:95-103.
13. Unrath A, Juengling FD, Schork M, Kassubek J. Cortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study. Mov Disord 2007;22:1751-1756.
14. Etgen T, Draganski B, Ilg C, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. NeuroImage 2005;24:1242-1247.
15. Hornyak M, Ahrendts JC, Spiegelhalder K, et al. Voxel-based morphometry in unmedicated patients with restless legs syndrome. Sleep Med (in press).
16. Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006;7:25-30.
17. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999;52:932-937.
18. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000;54:502-504.
19. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2002;59:649-650.
20. Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med 2004;5:401-406.
21. Okun MS, Fernandez HH, Foote KD. Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia. Mov Disord 2005;20:500-501.
22. Driver-Dunckley E, Evidente VG, Adler CH, et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006;21:1287-1289.
23. Kedia S, Moro E, Tagliati M, Lang AE, Kumar R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63:2410-2412.
24. Lee JS, Lee PH, Huh K. Periodic limb movements in sleep after a small deep subcortical infarct. Mov Disord 2005;20:260-261.
25. Unrath A, Kassubek J. Symptomatic restless leg syndrome after lacunar stroke: a lesion study. Mov Disord 2006;21:2027-2028.
26. Poewe W, Hogl B. Akathisia. restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004;63(8, Suppl 3):S12-S16.
27. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-424.
28. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-36.
29. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003;18:181-185.
30. Nomura T, Inoue Y, Miyake M, Yasui K, Nakashima K. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 2006;21:380-384.
31. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002;58:1019-1024.
32. Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000;23:361-367.
33. Wetter TC, Trenkwalder C, Gershanik O, Hogl B. Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Woehenschr 2001;113:249-253.
34. Garcia-Borreguero D, Caminero AB, De La Llave Y, et al. Decreased phasic FMG activity during rapid eye movement sleep in treatment-naive Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov Disord 2002;17:934-941.
35. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005;58:630-634.
36. Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord 2007;22:187-192.
37. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265.
38. Earley CJ, P BB, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 2006;7:458-461.
39. Connor JR, Boyer PJ, Menzics SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
40. Haba-Rubio J, Stane'r L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 2005;76:1009-1010.
41. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005;4:465-475.
42. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15:154-158.
43. Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;5:878-886.
44. Zhao H, Zhu W, Pan T, et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 2007;85:1065-1076.
45. Qu S, Ondo WG, Zhang X, Xie WJ, Pan TH, Le WD. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res 2006;168:152-156.
46. Baier PC, Ondo WG, Winkelmann J. Animal studies in restless legs syndrome. Mov Disord 2007;22 (Suppl. 18):S459-465).
47. Qu S, Le W, Zhang X, Xie W, Zhang A, Ondo WG. Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 2007;66:383-388.
48. Jud C, Schmutz I, Hampp G, Oster H, Albrecht U. A guideline for analyzing circadian wheel-running behavior in rodents under different lighting conditions. Biol Proced Online 2005;7:101-116.
49. Dean T, Jr., Allen RP, O'Donnell CP, Earley CJ. The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med 2006;7:634-640.
50. Garcia-Borreguero D, Allen RP, Benes H, et al. Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov Disord 2007;22 (Suppl. 18):S476-S484.
51. Trenkwalder C, Högl C, Benes H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Medicine (in press).
52. Zhao H, Zhu W, Pan T, et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 2007;85:1065-1076.
53. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006;67:125-130.
54. Paulus W, Schomburg ED. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis of augmentation? Sleep Med Rev 2006;10:185-196.
55. Trenkwalder C, Paulus W. Why do restless legs occur at rest? - pathophysiology of neuronal structures in RLS. Neurophysiology of RLS, Part 2. Clin Neurophysiol 2004;115:1975-1988.
56. Schols L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome? Neurology 1998;51:1603-1607.
57. Abele M, Burk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol 2001;248:311-314.
58. Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000;54:1609-1616.
59. Rijsman RM, Stam CJ, de Weerd AW. Abnormal H-reflexes in periodic limb movement disorder: impact on understanding the pathophysiology of the disorder. Clin Neurophysiol 2005;116:204-210.
60. Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004;127 (Part 4):773-782.
61. Lee MS, Choi YC, Lee SH, Lee SB. Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord 1996;11:719-722.
62. Hogl B, Frauscher B, Seppi K, Ulmer H, Poewe W. Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology 2002;59:1705-1707.
63. Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede R-D. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004;127:773-782.
64. Salvi F, Montagna P, Plasmati R, et al. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry 1990;53:522-525.
65. Gemignani F, Marbini A, Di Giovanni G, et al. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome. J Neurol Sci 1997;152:218-223.
66. Gemignani F, Marbini A, Di Giovanni G, Salin S, Terzano MG. Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 1999;52:1064-1066.
67. Iannaccone S, Zucconi M, Marchettini P, et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 1995;10:2-9.
68. Happe S, Zeitlhofer J. Abnormal cutaneous thermal thresholds in patients with restless legs syndrome. J Neurol 2003;250:362-365.
69. Polydefkis M, R.P. A, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000;55:1115-1121.
70. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996;19:670-672.
71. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol 2004;251:977-982.
72. Sommer M, Bachmann CG, Liebetanz KM, Schindehutte J, Tings T, Paulus W. Pregabalin in restless legs syndrome with and without neuropathic pain. Acta Neurol Scand 2007;115:347-350.
73. Fields HL, Emson PC, Leigh BK, Gilbert RF, Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature 1980;284:351-353.
74. Rooney KF, Sewell RD. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception. Eur J Pharmacol 1989;168:329-336.
75. Winkelmann J, Lichtner P, Schormair P, et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord (in press).
76. Mignot E. A step forward for restless legs syndrome. Nat Genet 2007;39:938-939.
77. Winkelman JW. Periodic limb movements in sleep - endophenotype for restless legs syndrome? N Engl J Med 2007;357:703-705.
78. Winkelmann J, Polo O, Provini F, et al. Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord 2007;22 (Suppl. 18)S449-S458.
79. Cheng L, Samad OA, Xu Y, et al. Lbx1 and Tlx3 are opposing switches in determining GABAergic versus glutamatergic transmitter phenotypes. Nat Neurosci 2005;8:1510-1515.
80. Gross MK, Dottori M, Goulding M. Lbx1 specifies somatosensory association interneurons in the dorsal spinal cord. Neuron 2002;34:535-549.